What is the most common complication of β‑thalassemia major in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Complications of Thalassemia Major in Pregnancy

The most common complications of β-thalassemia major in pregnancy are cardiac complications (occurring in 1.1-15.6% of cases), followed by spontaneous miscarriage/fetal loss (9-33.3%), and obstetric complications including gestational diabetes, preeclampsia, and hypertension. 1

Cardiac Complications

Cardiac complications represent the primary maternal risk and occur in 1.1% to 15.6% of pregnancies in women with thalassemia major. 1 The mechanism involves:

  • Iron overload-related cardiac dysfunction that is exacerbated during pregnancy due to increased blood volume, changes in blood pressure, and interruption of chelation therapy due to teratogenic concerns 1
  • Increased blood consumption during pregnancy (to maintain hemoglobin around 10 g/dL) combined with cessation of chelation significantly worsens iron overload 1
  • Pre-existing cardiac iron burden is the critical determinant—cardiac T2* assessment and functional evaluation before conception are essential 1

Key Management Points:

  • Cardiac T2 and function must be assessed before conception* to identify women at highest risk 1
  • Cardiac function requires careful monitoring throughout pregnancy due to the hemodynamic stress of increased blood volume 1
  • Restarting iron chelation with deferoxamine toward the end of the second trimester should be considered in patients with severe heart or liver iron overload 1

Pregnancy Loss and Fetal Complications

Spontaneous miscarriage and fetal loss occur in 9% to 33.3% of pregnancies in women with thalassemia major. 1 Additional fetal/obstetric risks include:

  • Preterm births occur at increased rates due to underlying maternal or obstetric complications 1
  • Twin or triplet pregnancies are common (19% in one cohort) because most women require induction of ovulation due to hypogonadism-related impaired fertility 2

Obstetric Complications

Obstetric complications including gestational diabetes, preeclampsia, and hypertension are reported frequently in thalassemia major pregnancies. 1

  • Cesarean delivery rates range from 24% to 100% due to fetopelvic disproportion, osteoporosis, maternal HIV infection, or patient choice 1
  • Thromboembolism prophylaxis with heparin or low-molecular-weight heparin is indicated, particularly in splenectomized patients 1

Iron Overload Progression

Iron accumulation increases significantly during pregnancy, especially in the liver. 2 In one cohort:

  • Median ferritin levels increased from 1071 ng/ml before pregnancy to 2231 ng/ml after pregnancy (p < 0.0001) 2
  • Mean liver iron concentration increased from 3.37 mg/g dry weight to 9.06 mg/g dry weight (p = 0.0001) after pregnancy 2
  • Prompt resumption of chelation after delivery is mandatory to prevent long-term organ damage 2

Critical Pitfalls to Avoid

  • Do not delay cardiac assessment—women with preexisting cardiac disease or large amounts of cardiac iron have substantially increased maternal risk 1
  • Do not manage these pregnancies in non-expert centers—such pregnancies require a multidisciplinary team at expert centers due to increased risk to mother and baby 1
  • Do not forget thromboprophylaxis—particularly critical in splenectomized patients 1
  • Do not delay resumption of chelation postpartum—iron accumulation during pregnancy necessitates aggressive chelation after delivery 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.